The next-generation pan-RAF inhibitor, KIN-2787, is active in class II and class III BRAF mutant models.Aleksandra Franovic,Nichol Miller,Paul Severson,Toufike Kanouni,Noelito Timple, Ping Jiang,Eric Murphy,Eric MartinJOURNAL OF CLINICAL ONCOLOGY(2021)引用 4|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要